Plain-English translation of NCT07184957 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study is building a database to track how men do after receiving cryotherapy—a freezing treatment—for early-stage prostate cancer. Researchers will collect information about your health before treatment and then follow your progress afterward to understand how well this approach works and what outcomes men experience.
Cryotherapy is an option for men with early prostate cancer, but doctors need more detailed information about how it performs over time and how it affects patients' quality of life compared to other treatment choices.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll allow the research team to collect your medical information before your cryotherapy procedure and then track your health outcomes afterward. This is a registry study, meaning you're primarily sharing your existing medical data and treatment results rather than undergoing additional experimental procedures. The team will monitor how you respond to treatment and record any side effects or complications.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States
Enrollment target
~1,000 participants
Started
May 2017
Primary completion
December 2030
Age range
40 Years – 85 Years
Sex
Male only
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Majlinda Tafa
NYU Langone Health
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.